Launching a Botanical Capsule in January: A Private-Label Timeline Working Back From Shelf Date
Buyer’s snapshot
- The manufacturer-side steps for a private-label botanical capsule add up to about 13 to 14 weeks by sea (formulation up to 4 weeks, sample 1 to 2 weeks, production 2 to 3 weeks, sea freight 3 to 5 weeks) and about 9 to 10 weeks by air, before any buyer-side buffer.
- Working back from a 15 January 2027 shelf date with a 2-week receiving buffer, the latest signed brief is 2 October for sea freight to the EU or Australia and 26 October for air freight.
- Label approval and market-specific claim steps sit with the brand, not the manufacturer. In the US, FDA must be notified within 30 days of first marketing a structure/function claim.
- Silk Foods Ceylon (SFC) runs capsules at 100,000 per shift and 200,000 per day under BRCGS and FSSC 22000 V6, with a 180-bottle MOQ per shift.
- These are planning ranges, not a promised shelf date. Freight, customs and retailer receiving windows sit outside any manufacturer’s control.
New-year wellness launches are planned in the autumn, and the usual failure is the same: a brand starts at the shelf date and counts forward, instead of starting at the shelf date and counting back. This brief is for nutraceutical and wellness brand teams in the US, EU, UK and Australia who want a January capsule on the shelf and need to know which steps belong to whom, and how long each one takes.
What does a private-label capsule timeline actually contain?
A private-label capsule launch has six steps: formulation, sample, label and claims sign-off, production, freight, and receiving. SRV’s trade desk works to formulation up to 4 weeks, sample 1 to 2 weeks, production 2 to 3 weeks from PO to dispatch, and sea freight of 3 to 5 weeks depending on destination. Label work runs in parallel and belongs to the brand.
| Step | Owner | Duration | Notes |
|---|---|---|---|
| Formulation, signed brief to approved formula | SRV R&D and NPD | 3 to 4 weeks at most | Skipped if the brand chooses an existing catalogue formulation |
| Sample production and dispatch | SFC and SRV trade desk | 1 to 2 weeks | Courier transit (DHL, FedEx, UPS) is 3 to 5 business days of that |
| Label artwork, claims review, market notifications | Brand | Brand’s own schedule | Runs in parallel with formulation and sample |
| Production, PO to dispatch | SFC | 2 to 3 weeks | PO follows sample approval and label sign-off |
| Freight | Shared | Sea: 3 to 4 weeks to EU or Australia, 4 to 5 weeks to the US. Air: 3 to 4 days | Air is port to port or airport to airport, before ground handling |
| Customs, receiving, retailer or 3PL booking | Brand | Allow 1 to 2 weeks | A planning assumption, not an SRV figure |
The R&D figure is a ceiling. SRV does not quote a formulation band longer than 3 to 4 weeks, and a brand that picks an existing formulation, such as the ashwagandha capsules, starts the clock at the sample step instead. For a worked view of what a capsule run involves, the capsule and powder co-manufacturing capacity guide covers batch sizes and line capacity.
How do you work back from a January shelf date?
Add the manufacturer-side steps for your route, add your own receiving buffer, and subtract the total from the shelf date. For a 15 January 2027 shelf date, the latest signed brief ranges from 25 September to 26 October depending on route and formulation, which is why sea freight to the US is already out of reach for a first full order.
| Route | SRV-side weeks (maximum) | Plus 2-week receiving buffer | Latest signed brief for 15 Jan 2027 |
|---|---|---|---|
| Sea to US, new formulation | 4 + 2 + 3 + 5 = 14 | 16 | 25 September 2026 |
| Sea to EU or Australia, new formulation | 4 + 2 + 3 + 4 = 13 | 15 | 2 October 2026 |
| Sea to US, existing catalogue formulation | 2 + 3 + 5 = 10 | 12 | 23 October 2026 |
| Air, new formulation | 4 + 2 + 3 + under 1 = about 9.5 | about 11.5 | 26 October 2026 |
The table uses every maximum, so it is deliberately cautious. Two readings matter most. A brand that reads this in early October and wants a US shelf date of 15 January has already used up its sea-freight margin on a new formulation. The options are an existing formulation, air freight for the first lot, or a later shelf date. One workable approach is to split the first order: a small air lot to hit the date, and the main volume by sea to replenish.
A procurement-side observation
Consider a brand that confirms its formulation in November, then learns in December that label artwork needs a second round, and the PO cannot be released until the label is final. A hypothetical, but a common shape. Nothing slowed on the manufacturing side in that case. The dependency sat in the brand’s own calendar. Opening label artwork on the day the brief is signed removes the most common cause of a missed January window.
What stays with the brand, not the manufacturer?
Three things stay with the brand under a private-label model: the label and its claims, the regulatory filings in the destination market, and responsibility for the finished product it releases. FDA’s compliance guidance for dietary supplement cGMP states that the firm arranging contract services and then distributing the packaged and labelled product is responsible for the supplement it releases.
The market-specific points differ:
- United States. A supplement with a structure/function claim needs the standard FDA disclaimer and a notification to FDA within 30 days of first marketing the claim. FDA does not approve the claim beforehand. The FDA notification page lists what the notice must contain.
- Australia. Most botanical capsules are listed medicines. The Therapeutic Goods Administration (TGA) does not assess a listed medicine individually before it enters the register; the sponsor certifies that it holds the evidence for the indications it claims. The brand needs an Australian sponsor before the listing can be lodged, so start that early.
- European Union and United Kingdom. Any health claim must be on the authorised list under Regulation (EC) No 1924/2006 (retained in UK law), and some botanicals face national restrictions that change over time. Confirm the ingredient and the claim for each market before artwork is final.
None of this is advice for a specific product; the brand’s regulatory lead should confirm it for each SKU. The point for the calendar is simple: each item above has its own lead time and none of them can be compressed by the manufacturer.
Which steps can run in parallel to save weeks?
Four steps can overlap without changing the quality of the result. Label artwork starts on the day the brief is signed. Market notifications are prepared while samples are in transit. Packaging specification, bottle size and count per bottle are confirmed during formulation. Freight booking opens as soon as the production date is confirmed.
What cannot overlap is the sequence of approvals: the sample must be approved before the PO, and the PO released before production. A short, structured sample review (capsule fill weight, disintegration, appearance, label fit) usually saves more time than any freight option. For the sample stage, the trade desk ships by international courier and asks for a written approval or one list of changes, not several rounds of small edits.
The 180-bottle MOQ per shift also shapes the calendar. A first order that small does not need a large production slot, and a brand testing a new SKU for January can commit to one shift of one formulation and add volume once sell-through is visible. The 180-bottle MOQ explainer sets out the unit economics, and the low-MOQ guide covers when a small first order is the right call.
What does the Silk Foods Ceylon capsule line deliver?
SFC fills capsules at 100,000 per single shift and 200,000 per day at its Matale facility in the Central Province, under BRCGS and FSSC 22000 V6. USDA Organic and EU Organic apply per SKU. The facility is registered with the Sri Lanka Department of Ayurveda and is an FDA-registered facility, which US brands typically check before anything else.
Every dispatched order ships with the standard documentation pack: commercial invoice, packing list, bill of lading or air waybill, certificate of origin, phytosanitary certificate where it applies, and a batch certificate of analysis. Orders under $10,000 are paid 100% in advance by bank transfer. Orders of $10,000 or above run 50% advance and 50% against scanned shipping documents. PayPal is accepted for samples only.
Botanical inputs for the capsules come from the same supply base as the Sri Lankan herbs range, and the herbal supplement capsules overview describes the formats available. For a formulation-specific example, the ashwagandha capsule spec shows how an assay and dosage are written into the brief.
Where the Silk Route Ventures model doesn’t fit
A brand that needs a fixed shelf date guaranteed in writing: no manufacturer or forwarder can promise customs and freight timing, and SRV will not. A brand that needs a retailer-specific registration done on its behalf, or a launch inside 8 weeks of signing a new formulation by sea. For those briefs the answer is a later date, or air freight and an existing formulation.
Frequently asked questions
How long does it take to make a private-label capsule from brief to shipment?
For a new formulation, the SRV trade desk plans formulation up to 4 weeks, sample 1 to 2 weeks, and production 2 to 3 weeks from PO to dispatch, so roughly 6 to 9 weeks before freight. Choosing an existing catalogue formulation removes the formulation step and brings that figure to about 3 to 5 weeks.
How long does freight take from Sri Lanka for a capsule order?
Sea freight is 3 to 4 weeks to the EU or Australia and 4 to 5 weeks to the US. Air freight, port to port or airport to airport, is 3 to 4 days before ground handling at either end. Courier samples travel door to door in 3 to 5 business days. Customs and last-mile delivery are additional and depend on the destination.
Does Silk Route Ventures offer private label for botanical capsules with a low MOQ?
Yes. Silk Foods Ceylon’s capsule line sets a MOQ of 180 bottles per single shift, with capacity of 100,000 capsules per shift and 200,000 per day. Production runs under BRCGS and FSSC 22000 V6 in Matale, and the SRV R&D and NPD team develops custom formulations within 3 to 4 weeks at most.
Which parts of the launch does the brand have to handle?
The brand owns the label, its claims and the filings for each destination market. In the US that includes the FDA structure/function notification within 30 days of first marketing, and in Australia a TGA sponsor and listing. The manufacturer supplies the formulation, the finished capsules, the batch certificate of analysis and the shipping documents.
How Silk Route Ventures can help
Silk Route Ventures (SRV) manufactures nutraceutical capsules and supplies bulk Ayurvedic and functional botanicals to wellness brands globally. The Silk Foods Ceylon facility in Matale holds BRCGS and FSSC 22000 V6, with USDA Organic and EU Organic on the relevant SKUs. Capsule MOQ is 180 bottles per single shift, samples ship by international courier in 3 to 5 business days, and the R&D and NPD team develops custom blends within 3 to 4 weeks at most. For a January launch, the useful first step is to send the target shelf date and destination market, so the trade desk can back-plan the route with you. Contact us to send an inquiry or request a sample.
Sources
- U.S. Food and Drug Administration, Notifications for Structure/Function and Related Claims in Dietary Supplement Labeling (30-day notification and required disclaimer). https://www.fda.gov/food/information-industry-dietary-supplements/notifications-structurefunction-and-related-claims-dietary-supplement-labeling (retrieved 2 October 2026)
- U.S. Food and Drug Administration, Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements (21 CFR Part 111; responsibility of the firm that arranges contract services). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling (retrieved 2 October 2026)
- Therapeutic Goods Administration (Australia), Understanding listed and registered complementary medicine regulation (listed medicines, sponsor certification, no individual pre-market assessment). https://www.tga.gov.au/resources/guidance/understanding-listed-and-registered-complementary-medicine-regulation (retrieved 2 October 2026)
- Regulation (EC) No 1924/2006 on nutrition and health claims made on foods. https://eur-lex.europa.eu/eli/reg/2006/1924/oj (retrieved 2 October 2026)
Written by the Silk Route Ventures Trade Team. Silk Route Ventures (E-Silk Route Ventures Ltd) is a Sri Lankan B2B supply-chain operator for the Food, Beverage, Wellness, and Nutraceuticals sectors. The Silk Foods Ceylon manufacturing arm holds BRCGS and FSSC 22000 V6 certifications. Questions or to request a sample: Contact us or email info@esilkroute.com.lk.